Sorrento Thera

SRNE NASDAQ
3.370
-0.190
-5.34%
After Hours: 3.350 -0.02 -0.59% 17:59 06/26 EDT
Open
3.470
Prev Close
3.560
High
3.543
Low
3.270
Volume
1.11M
Avg Vol (3M)
1.38M
52 Week High
7.55
52 Week Low
1.800
% Turnover
0.91%
Market Cap
413.00M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Sorrento Thera SRNE stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Sorrento Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, acquisition, development and commercialization of drug therapeutics. Its primary therapeutic focus is oncology, including the treatment of chronic cancer pain. It is also developing therapeutic products for other indications, including immunology and infectious diseases. Its products in the pipeline include Chimeric Antigen Receptor-T Cell (CAR-T) programs, resiniferatoxin (RTX), and biosimilar/biobetter antibodies clinical development programs. Its pipeline also includes preclinical fully human therapeutic monoclonal antibodies (mAbs), including biosimilars/biobetters, fully human anti-PD-L1 and anti-PD-1 checkpoint inhibitors derived from its G-MAB library platform, antibody drug conjugates (ADCs), bispecific antibodies (BsAbs), as well as CAR-T and Chimeric Antigen Receptor Natural Killer (NK) cells (CAR. NK) for adoptive cellular immunotherapy.
MORE >

Recently

Name
Price
%Change